茂化實華(000637.SZ):實華東成與清大公司共設山東艾瓦瑞能源科技
格隆匯3月9日丨茂化實華(000637.SZ)公佈,為適應發展和業務拓展需要,公司控股子公司茂名實華東成化工有限公司(“實華東成”)與北京清大環科電源技術有限公司(“清大公司”)以自有資金出資、在山東省淄博市投資設立山東艾瓦瑞能源科技有限公司,註冊資本為2100萬元人民幣,實華東成認繳出資1533萬元人民幣,持股73%,清大公司認繳出資567萬元人民幣,持股27%,實華東成為山東艾瓦瑞能源科技有限公司之控股股東。近日,經淄博市市場監督管理局核准,山東艾瓦瑞能源科技有限公司完成了工商登記手續並取得了營業執照。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.